Topic: Food and Drug Administration

Experimental diet drug keeps weight off for 2 years

NEW YORK (Reuters Health) - An experimental diet drug seems to help some obese people shed pounds, and keep them off for two years, researchers report.The drug, which will be called Qnexa if it reaches the market, is a combination of the ...

Experimental obesity drug beats placebo again

NEW YORK (Reuters Health) - The experimental weight-loss drug lorcaserin may spur modest weight loss without the heart risks of some older drugs, a new clinical trial confirms -- though whether the medication will ever reach the market remains up in the ...

FDA rejects Orexigen's weight-loss drug Contrave

The US Food and Drug Administration on Tuesday declined to approve a weight loss drug by the California pharmaceutical company Orexigen, saying it must conduct more studies to rule out heart risks.The surprise announcement sent Orexigen stock plunging and came after an ...

U.S. rejects Orexigen diet drug over heart risks

NEW YORK (Reuters) - U.S. health regulators rejected Orexigen Therapeutics Inc's weight-loss drug and requested a clinical trial to resolve heart safety concerns, dealing a huge blow to what stood to be the first new diet pill in a decade.Its shares tanked ...

Industry debuts new U.S. food labels, critics pan

LOS ANGELES (Reuters) - U.S. grocers joined with food and drink makers to unveil a new system on Monday for putting nutritional information on packages ahead of plans from U.S. regulators, who have called for clear and accurate labels to help fight ...

US panel approves first obesity drug in a decade

An advisory panel to the US Food and Drug Administration on Tuesday gave its approval to an anti-obesity drug, in what could be the first new approved drug for losing weight in more than a decade.Contrave, a drug developed by the California-based ...
FDA panel backs benefits of expanding stomach band to less obese patientsA panel of federal health experts has recommended expanding approval of a stomach-shrinking band to help patients who are obese but lighter than patients currently recommended to receive the implant.The Food ...

Diet drug faces U.S. test after rivals fall short

WASHINGTON (Reuters) - The last of a trio of diet drug hopefuls faces scrutiny next week, after two rivals failed to convince U.S. regulators that marginal weight loss associated with their drugs made up for major health risks.Orexigen Therapeutics, which has partnered ...
In an effort to provide nutrition and yet make a profit, many food producers have found ways to produce more food on less land and prevent pests from destroying crops. Soda contains a great deal of high HFCS and those who drink ...
Heart disease can be prevented! Dr. James Beckerman is here to provide insights into how making small, livable lifestyle changes can have a real impact on your heart health.. In the past few weeks, we have seen sibutramine (Meridia) pulled from the ...
Previous